Access

Letters to Nature

Nature 401, 79-82 (2 September 1999) | doi:10.1038/43459; Received 21 May 1999; Accepted 16 July 1999

Cell transformation by the superoxide-generating oxidase Mox1

Young-Ah Suh1,3, Rebecca S. Arnold1,3, Bernard Lassegue2, Jing Shi1, Xiangxi Xu1, Dan Sorescu2, Andrew B. Chung2, Kathy K. Griendling2 & J. David Lambeth1

  1. Departments of Biochemistry and
  2. Medicine, Emory University Medical School, Atlanta, Georgia 30322, USA
  3. These authors contributed equally to this work.

Correspondence to: J. David Lambeth1 Correspondence and requests for materials should be addressed to J.D.L. (e-mail: Email: dlambe@bimcore.emory.edu).

Top

Reactive oxygen species (ROS) generated in some non-phagocytic cells are implicated in mitogenic signalling and cancer1, 2, 3, 4, 5, 6. Many cancer cells show increased production of ROS7, and normal cells exposed to hydrogen peroxide or superoxide show increased proliferation8 and express growth-related genes9, 10, 11. ROS are generated in response to growth factors, and may affect cell growth2, 3, 12, 13, for example in vascular smooth-muscle cells6, 13, 14, 15. Increased ROS in Ras-transformed fibroblasts correlates with increased mitogenic rate16. Here we describe the cloning of mox1, which encodes a homologue of the catalytic subunit of the superoxide-generating NADPH oxidase of phagocytes17, 18, gp91phox. mox1 messenger RNA is expressed in colon, prostate, uterus and vascular smooth muscle, but not in peripheral blood leukocytes. In smooth-muscle cells, platelet-derived growth factor induces mox1 mRNA production, while antisense mox1 mRNA decreases superoxide generation and serum-stimulated growth. Overexpression of mox1 in NIH3T3 cells increases superoxide generation and cell growth. Cells expressing mox1 have a transformed appearance, show anchorage-independent growth and produce tumours in athymic mice. These data link ROS production by Mox1 to growth control in non-phagocytic cells.